1. 323 Systemic administration of ladiratuzumab vedotin alone or in combination with pembrolizumab results in significant immune activation in the tumor microenvironment in metastatic breast cancer patients. (9th November 2020) Authors: Pusztai, Lajos; Lu, Hailing; Hale, Christopher; Grosse-Wilde, Anne; Specht, Jennifer; Modi, Shanu; Han, Hyo; Cortes, Javier; Oliveira, Mafalda; Garfin, Phillip; Wang, Zejing; Onsum, Matthew Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 89 First-in-human CAR T targets cleaved MUC1, the growth factor receptor form. (10th December 2020) Authors: Smagghe, Benoit; Stewart, Andrew; Huang, Pengyu; Swanson, Tyler; Page, Danica; Carter, Mark; Grant, Trevor; Specht, Jennifer; Bamdad, Cynthia Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 89 First-in-human CAR T targets cleaved MUC1, the growth factor receptor form. (9th November 2020) Authors: Smagghe, Benoit; Stewart, Andrew; Huang, Pengyu; Swanson, Tyler; Page, Danica; Carter, Mark; Grant, Trevor; Specht, Jennifer; Bamdad, Cynthia Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab‐paclitaxel for high‐risk early‐stage breast cancer. Issue 4 (13th March 2018) Authors: Cho, Eunpi; Wu, Qian; Rubinstein, Lena; Linden, Hannah; Gralow, Julie; Specht, Jennifer; Gadi, Vijayakrishna; Ellis, Georgiana Journal: Breast journal Issue: Volume 24:Issue 4(2018) Page Start: 610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer. (28th January 2016) Authors: Brown-Glaberman, Ursa; Marron, Marilyn; Chalasani, Pavani; Livingston, Robert; Iannone, Maria; Specht, Jennifer; Stopeck, Alison T. Other Names: Lichtinghagen Ralf Academic Editor. Journal: Disease markers Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTNI-02. TBCRC049: A PHASE II STUDY TO ASSESS THE SAFETY AND EFFICACY OF THE COMBINATION OF TUCATINIB, TRASTUZUMAB AND CAPECITABINE FOR THE TREATMENT OF LEPTOMENINGEAL METASTASIS IN HER2 POSITIVE BR1AST CANCER. (9th November 2020) Authors: Murthy, Rashmi; O'Brien, Barbara; Berry, Donald; Navin, Nicholas; Johnson, Jason; Gule-Monroe, Maria; Leone, Jose; Specht, Jennifer; Melisko, Michelle; Morikawa, Aki; Storniolo, Anna; Brufsky, Adam; Pohlmann, Paula; Park, Deric; Park, Ben; Krop, Ian; Lin, Nancy; Rimawi, Mothaffar; Wolff, Antonio;... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer. Issue 20 (10th July 2021) Authors: Connolly, Roisin M.; Leal, Jeffrey P.; Solnes, Lilja; Huang, Chiung-Yu; Carpenter, Ashley; Gaffney, Katy; Abramson, Vandana; Carey, Lisa A.; Liu, Minetta C.; Rimawi, Mothaffar; Specht, Jennifer; Storniolo, Anna Maria; Valero, Vicente; Vaklavas, Christos; Krop, Ian E.; Winer, Eric P.; Camp, Meliss... Journal: Journal of clinical oncology Issue: Volume 39:Issue 20(2021) Page Start: 2247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗